Covered recipient · General Payments record
MEREDITH RACHAEL MCDONALD
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2022–2024
$2,203.97
- Reported across 57 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Travel and Lodging | $1,310.95 | 2 |
| Food and Beverage | $260.37 | 15 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Bolton Medical Inc | $1,310.95 | 2 |
| Novo Nordisk AS | $113.10 | 6 |
| Abbott Laboratories | $53.60 | 3 |
| DEXCOM, INC. | $31.22 | 2 |
| GlaxoSmithKline, LLC. | $28.80 | 2 |
| PFIZER INC. | $19.31 | 1 |
| Amgen Inc. | $14.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $17.09 | 11/04/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124789543 | CMS |
| Abbott Laboratories | $17.64 | 11/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124789545 | CMS |
| Abbott Laboratories | $18.87 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1124789547 | CMS |
| Amgen Inc. | $14.34 | 08/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117323778 | CMS |
| Bolton Medical Inc | $868.95 | 12/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1150746800 | CMS |
| Bolton Medical Inc | $442.00 | 12/12/2024 | Travel and Lodging | Undisputed | 01/23/2026 | 1150746804 | CMS |
| Dexcom, Inc. | $14.80 | 04/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153321726 | CMS |
| Dexcom, Inc. | $16.42 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153321728 | CMS |
| GlaxoSmithKline, LLC. | $13.67 | 08/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116601495 | CMS |
| GlaxoSmithKline, LLC. | $15.13 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116221747 | CMS |
| Novo Nordisk Inc | $15.95 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096667393 | CMS |
| Novo Nordisk Inc | $17.85 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096682243 | CMS |
| Novo Nordisk Inc | $23.10 | 06/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096983447 | CMS |
| Novo Nordisk Inc | $16.30 | 07/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097799562 | CMS |
| Novo Nordisk Inc | $18.95 | 10/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096863978 | CMS |
| Novo Nordisk Inc | $20.95 | 11/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097162341 | CMS |
| PFIZER INC. | $19.31 | 12/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131194263 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.